Cashu
Celldex Therapeutics (CLDX): Analyst Views Reveal Mixed Sentiment on Future Prospects
2 days ago
Stocks
Health Care
cldx
Celldex Therapeutics
CLDX
-0.27 (-1.33%)
20.07
USD
At close at Jun 17, 20:35 UTC
Overview
Loading chart...
Key Stats
Market Cap
1.33B
Dividend Yield
0.00%
P/E Ratio
-7.45
EPS
-2.45
Revenue
7.02M
Avg. Volume
722.80K
About
What does CLDX do?
Celldex Therapeutics, based in Hampton, New Jersey, develops novel therapeutics targeting mast cell-mediated diseases and employs 160 staff. Their pipeline includes Barzolvolimab and the bispecific antibody CDX-585 for inflammatory diseases and oncology.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.